TIRZEE 7.5/0.5ML 1S

TIRZEE 7.5MG/0.5ML Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for advanced blood sugar control in Type 2 Diabetes Mellitus. It works by improving insulin secretion, reducing glucagon release, slowing gastric emptying, and significantly decreasing appetite. TIRZEE is also prescribed for weight management under medical supervision.

Uses of TIRZEE 7.5MG/0.5ML Injection

• Treatment of Type 2 Diabetes Mellitus

• Improving glycemic control

• Weight loss and obesity management (doctor advised)

• Reducing risk of diabetes-related complications

Benefits

• Dual action on GIP + GLP-1 receptors for superior glucose control

• Helps lower HbA1c levels effectively

• Promotes significant and sustained weight loss

• Reduces appetite and food cravings

• Improves insulin sensitivity

• Once-weekly injection for convenience and compliance

Side Effects

Common side effects include:

• Nausea

• Vomiting

• Diarrhea or constipation

• Abdominal discomfort

• Reduced appetite

• Fatigue

Rare but serious side effects:

• Pancreatitis (severe abdominal pain)

• Gallbladder problems

• Allergic reactions

Precautions

• Use strictly under medical supervision

• Not recommended for Type 1 diabetes

• Caution in patients with history of pancreatitis

• Avoid during pregnancy and breastfeeding

• Regular monitoring of blood sugar is advised

Storage Instructions

• Store in a refrigerator at 2°C–8°C

• Do not freeze

• Protect from direct sunlight and heat